Cargando…

Back to the Future: Rethinking the Great Potential of lncRNA(S) for Optimizing Chemotherapeutic Response in Ovarian Cancer

Ovarian cancer (OC) is one of the most fatal cancers in women worldwide. Currently, platinum- and taxane-based chemotherapy is the mainstay for the treatment of OC. Yet, the emergence of chemoresistance results in therapeutic failure and significant relapse despite a consistent rate of primary respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elsayed, Abdelrahman M., Amero, Paola, Salama, Salama A., Abdelaziz, Abdelaziz H., Lopez-Berestein, Gabriel, Rodriguez-Aguayo, Cristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564391/ https://www.ncbi.nlm.nih.gov/pubmed/32854207 http://dx.doi.org/10.3390/cancers12092406

Ejemplares similares

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
por: Elsayed, Abdelrahman M., et al.
Publicado: (2021)

Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer
por: Attia, Yasmin M., et al.
Publicado: (2020)

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer
por: Martinez-Castillo, Moises, et al.
Publicado: (2023)

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
por: Szymanowski, Wojciech, et al.
Publicado: (2023)

Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
por: Amero, Paola, et al.
Publicado: (2020)

Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment
por: Szymanowska, Anna, et al.
Publicado: (2023)

Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
por: Bayraktar, Emine, et al.
Publicado: (2023)

Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer
por: Chakraborty, Debaditya, et al.
Publicado: (2021)

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
por: Lara, Olivia D., et al.
Publicado: (2020)

Rethinking marketing: back to purpose
por: Fehrer, Julia A.
Publicado: (2020)

An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer
por: Hou, Jian, et al.
Publicado: (2022)

Chemotherapeutic Risk lncRNA-PVT1 SNP Sensitizes Metastatic Colorectal Cancer to FOLFOX Regimen
por: Wu, Shenshen, et al.
Publicado: (2022)

A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
por: Zhang, Yang, et al.
Publicado: (2022)

To Nutraceuticals and Back: Rethinking a Concept
por: Santini, Antonello, et al.
Publicado: (2017)

Role of LncRNA-AF085935, IL-10 and IL-17 in Rheumatoid Arthritis Patients With Chronic Hepatitis C
por: Sabry, Dina, et al.
Publicado: (2017)

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
por: Wang, Enfeng, et al.
Publicado: (2011)

Chemotherapeutic Potential of Epimedium brevicornum Extract: The cGMP-Specific PDE5 Inhibitor as Anti-Infertility Agent Following Long-Term Administration of Tramadol in Male Rats
por: Abdelaziz, Ahmed S., et al.
Publicado: (2020)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Rethinking the COVID-19 Pandemic: Back to Public Health
por: Collins, Téa, et al.
Publicado: (2020)

Role of lncRNA-ATB in ovarian cancer and its mechanisms of action
por: Yuan, Donglan, et al.
Publicado: (2020)

Low Expression of lncRNA-GAS5 Is Implicated in Human Primary Varicose Great Saphenous Veins
por: Li, Li, et al.
Publicado: (2015)

Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer
por: Zhou, Meng, et al.
Publicado: (2016)

The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3
por: Chen, Jingjing, et al.
Publicado: (2019)

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
por: Eckert, Mark A., et al.
Publicado: (2021)

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
por: Gao, Chao, et al.
Publicado: (2021)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

The lncRNA Toolkit: Databases and In Silico Tools for lncRNA Analysis
por: Pinkney, Holly R., et al.
Publicado: (2020)

Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression
por: Guo, Qiuyan, et al.
Publicado: (2015)

LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome formation
por: Li, Jie, et al.
Publicado: (2018)

Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
por: Liu, Fang, et al.
Publicado: (2022)

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
por: Kanlikilicer, Pinar, et al.
Publicado: (2017)

Ovarian Drilling: Back to the Future
por: Mercorio, Antonio, et al.
Publicado: (2022)

Towards unlocking the biocontrol potential of Pichia kudriavzevii for plant fungal diseases: in vitro and in vivo assessments with candidate secreted protein prediction
por: Elkhairy, Bassma Mahmoud, et al.
Publicado: (2023)

Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
por: Li, Yongsheng, et al.
Publicado: (2015)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

E2F1-induced lncRNA, EMSLR regulates lncRNA LncPRESS1
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Rethinking Integration of Environmental and Behavioral Stressors; Back to Energy Homeostasis and Function
por: Molina, Patricia E
Publicado: (2022)

The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
por: Ruan, Lingjuan, et al.
Publicado: (2018)

Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s6u1p5df3k8u6rfp1ki20s9mmt